Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more_老虎社区_美港股上老虎

Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more

StreetInsider2021-06-25

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

315

SerenityMie
·2021-06-26
Pls like n comment
回复
点赞
举报
ushouldknow
·2021-06-25
[财迷] [财迷] [财迷]
回复
点赞
举报
rhengheng
·2021-06-25
Like and comment please
回复
1
举报
收起
- 股神徒孙:
  Sure. Like and comment back. Thanks
  2021-06-25
  回复
  举报
Evekoh
·2021-06-25
Let see how it goes
回复
1
举报
ong1995
·2021-06-25
Solid companies
回复
1
举报
EDWINHLC
·2021-06-25
Read
回复
1
举报
leonleonxd
·2021-06-25
Wow
回复
2
举报
elynzj
·2021-06-25
Ok
回复
1
举报
Foxie
·2021-06-25
Good!! 🚀Please like and comment. I’ll comment back.
回复
7
举报
收起
- DMC8:
  To the moon🚀
  2021-06-25
  回复
  举报
- tig2021:
  Done
  2021-06-25
  回复
  举报
ahchan
·2021-06-25
Good
回复
4
举报
huijingy
·2021-06-25
Hi
回复
2
举报
41a25b3d
·2021-06-25
.
回复
1
举报
FlyingGogo
·2021-06-25
Something big is coming soon.....
回复
2
举报
Lululimmok
·2021-06-25
Like and comment thx
回复
4
举报
收起
- 可乐Coke:
  ok
  2021-06-25
  回复
  举报
- 41a25b3d:
  .
  2021-06-25
  回复
  举报
WoShiMLH
·2021-06-25
Like pls! Thank you!
回复
1
举报
dt1
·2021-06-25
[微笑]
回复
3
举报
Slee49
·2021-06-25
Good !
回复
3
举报
Erikca
·2021-06-25
Cool
回复
4
举报
Weeckee
·2021-06-25
After hours then move…
回复
5
举报
EmChung
·2021-06-25
Nice
回复
3
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2146202596?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-25 07:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2146202596","market":"us","top_or_hot":-1,"title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","media":"StreetInsider","content":"<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNX","symbol_name":"新聚思","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","article_id":"2146202596","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","pubTimestamp":1624578540,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","NKE":"耐克","TNXP":"Tonix Pharmaceuticals Holding Co"},"translate_title":"盘后涨幅最大的股票：耐克、联邦快递、美国银行等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FDX":0.9,"NKE":0.9,"SNCR":0.9,"SNX":0.9,"TBPH":0.9,"TNXP":0.9},"content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":125465110,"gmtCreate":1624687170230,"gmtModify":1633949555611,"author":{"id":"3581556843549192","authorId":"3581556843549192","name":"SerenityMie","avatar":"https://static.tigerbbs.com/7beaf0f50fa9c54132bac0579576b755","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pls like n comment","listText":"Pls like n comment","text":"Pls like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125465110","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122699695,"gmtCreate":1624614808017,"gmtModify":1633950522303,"author":{"id":"3573691386745177","authorId":"3573691386745177","name":"ushouldknow","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","listText":"[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","text":"[财迷] [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122699695","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122101165,"gmtCreate":1624601275557,"gmtModify":1633950654603,"author":{"id":"3577612953569737","authorId":"3577612953569737","name":"rhengheng","avatar":"https://static.tigerbbs.com/58bf6b16a89ff371c6c0942ad99039ea","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/122101165","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5011581,"gmtCreate":1624612218100,"gmtModify":1635246888377,"authorId":3573474804628073,"author":{"id":3573474804628073,"authorId":3573474804628073,"name":"股神徒孙","avatar":"https://static.tigerbbs.com/ac59f7fc64d3e018af70687bdddf30c2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122101165,"type":1,"supId":0,"prevId":0,"content":"Sure. Like and comment back. Thanks","text":"Sure. Like and comment back. Thanks","html":"Sure. Like and comment back. Thanks"}],"langContent":"EN"},{"id":122328428,"gmtCreate":1624598840964,"gmtModify":1633950682195,"author":{"id":"3584949492748909","authorId":"3584949492748909","name":"Evekoh","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Let see how it goes","listText":"Let see how it goes","text":"Let see how it goes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122328428","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122368811,"gmtCreate":1624598172333,"gmtModify":1633950690528,"author":{"id":"4087651624152100","authorId":"4087651624152100","name":"ong1995","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Solid companies","listText":"Solid companies","text":"Solid companies","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122368811","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122398624,"gmtCreate":1624596360068,"gmtModify":1633950723859,"author":{"id":"3582422606150116","authorId":"3582422606150116","name":"EDWINHLC","avatar":"https://static.tigerbbs.com/1713fcfede7d5ef4d896338f3a585a14","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122398624","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122984021,"gmtCreate":1624593108563,"gmtModify":1633950775033,"author":{"id":"3558581079351232","authorId":"3558581079351232","name":"leonleonxd","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122984021","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122914099,"gmtCreate":1624592623311,"gmtModify":1633950782155,"author":{"id":"3584528872593052","authorId":"3584528872593052","name":"elynzj","avatar":"https://static.tigerbbs.com/1eebec41932cb5587648b6ba43ac3e8b","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122914099","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122911257,"gmtCreate":1624592368179,"gmtModify":1633950785644,"author":{"id":"3572988793196593","authorId":"3572988793196593","name":"Foxie","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good!! 🚀Please like and comment.&nbsp;I’ll comment back.&nbsp;","listText":"Good!! 🚀Please like and comment.&nbsp;I’ll comment back.&nbsp;","text":"Good!! 🚀Please like and comment. I’ll comment back.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/122911257","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5008220,"gmtCreate":1624593681120,"gmtModify":1635247193121,"authorId":3579992296424941,"author":{"id":3579992296424941,"authorId":3579992296424941,"name":"DMC8","avatar":"https://static.tigerbbs.com/65aa8f5f6299558ce2ab36482793f750","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122911257,"type":1,"supId":0,"prevId":0,"content":"To the moon🚀","text":"To the moon🚀","html":"To the moon🚀"},{"id":5009770,"gmtCreate":1624601089339,"gmtModify":1635247038287,"authorId":3587008457873110,"author":{"id":3587008457873110,"authorId":3587008457873110,"name":"tig2021","avatar":"https://static.tigerbbs.com/86558e2c1be0fae967630b306994ef5a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122911257,"type":1,"supId":0,"prevId":0,"content":"<u>Done</u>","text":"<u>Done</u>","html":"<u>Done</u>"}],"langContent":"EN"},{"id":122996652,"gmtCreate":1624591476176,"gmtModify":1631891905560,"author":{"id":"3579309304980279","authorId":"3579309304980279","name":"ahchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122996652","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122908872,"gmtCreate":1624590978396,"gmtModify":1631892323473,"author":{"id":"3575589673350771","authorId":"3575589673350771","name":"huijingy","avatar":"https://static.tigerbbs.com/697ddc66d15c73794a2cad07fa4eee76","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122908872","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122073763,"gmtCreate":1624590371752,"gmtModify":1633950818200,"author":{"id":"3582279484837092","authorId":"3582279484837092","name":"41a25b3d","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122073763","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122020685,"gmtCreate":1624588941547,"gmtModify":1631893414538,"author":{"id":"3586653302706396","authorId":"3586653302706396","name":"FlyingGogo","avatar":"https://static.tigerbbs.com/88564dcc8d3149ddb7aed39e8ff8985a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Something big is coming soon.....","listText":"Something big is coming soon.....","text":"Something big is coming soon.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122020685","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122069403,"gmtCreate":1624588576202,"gmtModify":1633950847101,"author":{"id":"3582010686766598","authorId":"3582010686766598","name":"Lululimmok","avatar":"https://static.tigerbbs.com/fcb4102cffc589f4ab17c35dd6217cf0","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Like and comment thx&nbsp;","listText":"Like and comment thx&nbsp;","text":"Like and comment thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/122069403","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5007263,"gmtCreate":1624589769421,"gmtModify":1635247285391,"authorId":3582270537906794,"author":{"id":3582270537906794,"authorId":3582270537906794,"name":"可乐Coke","avatar":"https://static.tigerbbs.com/ad7deb4e9a6dac53889160d4c9fab864","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122069403,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5007423,"gmtCreate":1624590381089,"gmtModify":1635247270330,"authorId":3582279484837092,"author":{"id":3582279484837092,"authorId":3582279484837092,"name":"41a25b3d","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122069403,"type":1,"supId":0,"prevId":0,"content":".","text":".","html":"."}],"langContent":"EN"},{"id":122060102,"gmtCreate":1624588488306,"gmtModify":1633950847909,"author":{"id":"3586651000903281","authorId":"3586651000903281","name":"WoShiMLH","avatar":"https://static.tigerbbs.com/6341b0b9d62c0bd632fbaea9a3148714","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Like pls! Thank you!","listText":"Like pls! Thank you!","text":"Like pls! Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122060102","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122082255,"gmtCreate":1624588275077,"gmtModify":1633950851152,"author":{"id":"3577530901336464","authorId":"3577530901336464","name":"dt1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122082255","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122019986,"gmtCreate":1624587671445,"gmtModify":1633950863606,"author":{"id":"3581993357014262","authorId":"3581993357014262","name":"Slee49","avatar":"https://static.tigerbbs.com/a4a9c556617a3ec3446f5c1c667b4aa0","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Good !","listText":"Good !","text":"Good !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122019986","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122035041,"gmtCreate":1624587504083,"gmtModify":1633950866924,"author":{"id":"3582074233060171","authorId":"3582074233060171","name":"Erikca","avatar":"https://static.tigerbbs.com/4c8597dae5bbe585b053f307dd3255c0","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122035041","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122032202,"gmtCreate":1624587496906,"gmtModify":1633950867370,"author":{"id":"3582072953259355","authorId":"3582072953259355","name":"Weeckee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"After hours then move…","listText":"After hours then move…","text":"After hours then move…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122032202","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122039324,"gmtCreate":1624587255068,"gmtModify":1633950871383,"author":{"id":"3566723689439669","authorId":"3566723689439669","name":"EmChung","avatar":"https://static.tigerbbs.com/99db9b9b2d5d303db43970c31a6ba528","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122039324","repostId":2146202596,"repostType":4,"repost":{"id":"2146202596","pubTimestamp":1624578540,"share":"https://www.laohu8.com/m/news/2146202596?lang=&edition=full","pubTime":"2021-06-25 07:49","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2146202596","media":"StreetInsider","summary":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pha","content":"<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.</p>\n<p><a href=\"https://laohu8.com/S/THRX\">Theravance</a> Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p><a href=\"https://laohu8.com/S/SNCR\">Synchronoss Technologies, Inc.</a> (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.</p>\n<p>Nike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.</p>\n<p><a href=\"https://laohu8.com/S/OMP\">Oasis Midstream Partners LP</a> (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.</p>\n<p>FedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.</p>\n<p>Mirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.</p>\n<p>SYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.</p>\n<p>BlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.</p>\n<p>Bank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve&nbsp;announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Nike, FedEx, Bank of America and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Nike, FedEx, Bank of America and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603364><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603364\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNX":"新聚思","SNCR":"Synchronoss Technologies, Inc.","FDX":"联邦快递","TBPH":"Theravance Biopharma Inc.","TNXP":"Tonix Pharmaceuticals Holding Co","NKE":"耐克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603364","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146202596","content_text":"Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.\nTheravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSynchronoss Technologies, Inc. (NASDAQ: SNCR) 7.6% LOWER; announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.\nNike (NYSE: NKE) 7.2% HIGHER; reported Q4 EPS of $0.93, $0.43 better than the analyst estimate of $0.50. Revenue for the quarter came in at $12.3 billion versus the consensus estimate of $11.09 billion.\nOasis Midstream Partners LP (NASDAQ: OMP) 5.8% LOWER; Commenced an underwritten public offering of 3,623,188 common units representing limited partnership interests (\"common units\"). The Partnership expects to grant the underwriter a 30-day option to purchase up to an additional 543,478 common units.\nFedEx (NYSE: FDX) 4.2% LOWER; reported Q4 EPS of $5.01, $0.02 better than the analyst estimate of $4.99. Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.51 million. FDX sees FY22 EPS of $20.50 to $21.50 vs consensus of $20.37.\nMirati Therapeutics (NASDAQ: MRTX) 4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRASG12C mutation following prior systemic therapy.\nSYNNEX Corp. (NYSE: SNX) 2.4% LOWER; reported Q2 EPS of $2.09, $0.16 better than the analyst estimate of $1.93. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $4.96 billion. SYNNEX Corp. sees Q3 2021 EPS of $1.90-$2.10, versus the consensus of $1.99. SYNNEX Corp. sees Q3 2021 revenue of $4.95-5.46 billion, versus the consensus of $5.1 billion.\nBlackBerry (NYSE: BB) 1.3% HIGHER; reported Q1 EPS of ($0.05), in line with the analyst estimate of ($0.05). Revenue for the quarter came in at $174 million versus the consensus estimate of $171.25 million.\nBank of America,Goldman Sachs,Wells Fargo,JPMorgan— Shares of the major U.S. banks popped in after-hours trading after theFederal Reserve announced the banks couldeasily withstand a severe recession. The Fed, in releasing the results of its annual stress test, said that all 23 institutions in the 2021 exam remained \"well above\" minimum required capital levels during a hypothetical economic downturn. Bank of America and Wells Fargo each rose about 1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":315,"commentSize":85,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}